Here is a structured treatment breakdown for each finding in the ultrasound report:
USG Findings & Management - Mrs. Rekha Bhaskaran
1. Left Ovarian Serous Cyst (5.5 x 4.5 cm)
What it is: A simple-appearing cyst with clear fluid and a thin septum. No solid components, no calcification, no abnormal vascularity - these are reassuring features against malignancy. The "?" in the impression means the radiologist considers it likely benign but not definitively diagnosed yet.
Management:
- First step: Gynecology referral + serum CA-125 to complete risk assessment (IOTA/RCOG criteria for simple cysts).
- Cysts < 5 cm in premenopausal women: watchful waiting with repeat USS at 3-6 months is standard.
- This cyst is 5.5 cm - it sits in the "watch closely" zone. Most guidelines (RCOG, ACOG) recommend:
- Serial ultrasound follow-up every 3-6 months for 1 year if CA-125 is normal
- If it persists, enlarges, or develops new features - laparoscopic cystectomy (ovary-preserving surgery)
- Spontaneous resolution occurs in a significant proportion of premenopausal women within 3 months.
- No medical therapy shrinks serous cysts - OCPs do not help once a functional cyst has formed.
2. Uterine Fibroid (2.8 cm) + Bulky Uterus + Thick Endometrium (12 mm)
This combination needs attention. Endometrial thickness of 12 mm is above normal for the secretory phase (~10-16 mm max) but must be interpreted in context of cycle day and menopausal status.
For the fibroid (2.8 cm intramural/submucosal - location not specified):
| Approach | Indication |
|---|
| Conservative (no treatment) | Asymptomatic, fibroid < 3 cm, not distorting cavity |
| Medical - GnRH agonist (leuprolide/goserelin) | Pre-operative downsizing for 3-6 months; reduces fibroid size and blood loss at surgery |
| Hysteroscopic myomectomy | Submucosal fibroids causing abnormal uterine bleeding (AUB) |
| Laparoscopic myomectomy | Subserosal/intramural fibroids, fertility desired |
| Hysterectomy | Completed family, symptomatic, failed medical therapy |
| Uterine artery embolization (UAE) | Minimally invasive option for single large fibroid; less suitable for multifibroid uterus |
(- Katzung's Basic & Clinical Pharmacology, p. 1057; Schwartz's Principles of Surgery, p. 1825)
For the thick endometrium (12 mm):
- The key question is: is she pre- or postmenopausal? If postmenopausal, 12 mm endometrium is abnormal and requires endometrial biopsy (Pipelle) or hysteroscopy with D&C to exclude hyperplasia or carcinoma.
- If premenopausal with irregular bleeding, hysteroscopy + directed biopsy is recommended.
- Endometrial thickness ≥ 5 mm in a postmenopausal woman, or associated with AUB in a premenopausal woman, warrants histological sampling.
3. Paraumbilical Hernia (3 cm defect, omentum in sac, no bowel)
What it shows: A 3 cm defect with omentum herniated - no bowel loops involved, no signs of obstruction or strangulation. This is currently reducible/non-strangulated.
Management:
- Elective surgical repair is recommended for all paraumbilical hernias in adults because:
- They do not resolve spontaneously
- Risk of incarceration/strangulation increases with time
- Omentum in the sac already indicates content - risk of bowel involvement later
- Surgical options:
- Open Mayo's repair (vest-over-pants technique) - traditional approach for small/medium defects
- Mesh repair (open or laparoscopic) - preferred for defects > 2 cm; lower recurrence rate than primary suture repair
- Given this is a 3 cm defect, mesh repair is preferred (primary suture repair has higher recurrence for defects > 1-2 cm)
- Timing: Elective (not emergency) since no bowel is involved and no obstruction is present.
Summary Action Plan
| Finding | Priority | Next Step |
|---|
| Ovarian serous cyst (5.5 cm) | Moderate | Gynecology OPD + CA-125; repeat USS at 3 months |
| Fibroid + thick endometrium 12 mm | Moderate-High | Gynecology OPD - endometrial biopsy to rule out hyperplasia, assess symptoms |
| Paraumbilical hernia (3 cm) | Elective | Surgery OPD - plan mesh hernioplasty |
Important: This report represents radiological findings only. Clinical correlation (symptoms, menstrual history, menopausal status, family history of ovarian/endometrial cancer) is essential before finalizing any treatment plan. The patient should be seen by a gynecologist and a general surgeon as the next steps.